Independent Study Utilizing Cyclic Levulan PDT Finds 95 Percent Reduction In New Squamous Cell Carcinoma Lesions In Solid Organ Transplant Recipients
The results of an independent investigator study just published in the online version of Dermatologic Surgery demonstrate that Levulan(®) Photodynamic Therapy (PDT) may reduce the rate of recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), a population with a high incidence of nonmelanoma skin cancer.
Posted by SkinDoc on Wednesday, November 11, 2009, at 11:20 am. Filed under Skin Care News. Tagged Carcinoma, Cell Carcinomas, Independent Investigator, Independent Study, Lesions, Levulan Pdt, Organ Transplant Recipients, Photodynamic Therapy Pdt, Population, Recurrence, Sccs, Skin Cancer, Squamous Carcinoma, Squamous Cell Carcinoma.
Both comments and trackbacks are currently closed.
